Company intelligence / Profile preview

Algentech

Evry-Courcouronnes, Ile-de-France, France
Ownership
Private
Employees
~8
Development stage
Other
01

Overview

Algentech is a private French green biotech company focused on synthetic biology and plant-based bioproduction. The company uses proprietary chloroplast engineering, genome-editing, and self-replicating minichromosome technologies to turn plants into green factories for the production of high-value biomolecules and active ingredients. Its platform is positioned for multisector applications spanning pharmaceuticals, cosmetics, food, agritech, and industrial biobased products rather than a traditional human therapeutic pipeline. Publicly described products include melanin, antimicrobial proteins, and linear and circular RNAs, alongside partner-facing proof-of-concept and licensing offerings. Algentech appears to operate primarily as a platform and ingredient/technology company rather than a clinical-stage drug developer.

Therapeutic areas
Other
Modalities
BiologicProteinRNA therapy
Industry
Non-Drug Biotech
02

Partnerships

Unnamed French seed company for corn genome targeting testsUnnamed American multinational for a chloroplast production projectUnnamed partner for development of new soybean linesEuropean Space Agency funded project for perchlorate- and radiation-resistant plants

Beyond the preview

Go deeper on Algentech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Algentech.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call